Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP.

J Clin Oncol. 2011 Mar 10;29(8):957-62. doi: 10.1200/JCO.2009.26.4655. Epub 2011 Jan 31.

PMID:
21282539
2.

Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.

Mead GM, Fossa SD, Oliver RT, Joffe JK, Huddart RA, Roberts JT, Pollock P, Gabe R, Stenning SP; MRC/EORTC seminoma trial collaborators.

J Natl Cancer Inst. 2011 Feb 2;103(3):241-9. doi: 10.1093/jnci/djq525. Epub 2011 Jan 6.

PMID:
21212385
3.

Carboplatin in clinical stage I seminoma: too much and too little at the same time.

Bosl GJ, Patil S.

J Clin Oncol. 2011 Mar 10;29(8):949-52. doi: 10.1200/JCO.2010.29.5055. Epub 2011 Jan 31. No abstract available.

PMID:
21282532
4.

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP; MRC TE19 collaborators and the EORTC 30982 collaborators.

Lancet. 2005 Jul 23-29;366(9482):293-300.

5.

Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.

Porcaro AB, Antoniolli SZ, Schiavone D, Maffei N, Bassetto MA, Curti P.

Arch Ital Urol Androl. 2002 Jun;74(2):77-80. Review.

PMID:
12161941
6.

Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.

Porcaro AB, Antoniolli SZ, Maffei N, Beltrami P, Bassetto MA, Curti P.

Arch Ital Urol Androl. 2002 Jun;74(2):81-5. Review.

PMID:
12161942
7.

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.

Chau C, Cathomas R, Wheater M, Klingbiel D, Fehr M, Bennett J, Markham H, Lee C, Crabb SJ, Geldart T.

Ann Oncol. 2015 Sep;26(9):1865-70. doi: 10.1093/annonc/mdv254. Epub 2015 Jun 2.

PMID:
26037797
8.

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.

Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, Horwich A, Mason MD, Huddart RA.

Radiother Oncol. 2001 Apr;59(1):5-11.

PMID:
11295200
9.

Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.

Dieckmann KP, Matthies C, Kliesch S.

J Clin Oncol. 2011 Jul 20;29(21):2944-5; author reply 2945-6. doi: 10.1200/JCO.2011.35.7970. Epub 2011 Jun 13. No abstract available.

PMID:
21670458
10.

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

Aparicio J, Germà JR, García del Muro X, Maroto P, Arranz JA, Sáenz A, Barnadas A, Dorca J, Gumà J, Olmos D, Bastús R, Carles J, Almenar D, Sánchez M, Paz-Ares L, Satrústegui JJ, Mellado B, Balil A, López-Brea M, Sánchez A; Second Spanish Germ Cell Cancer Cooperative Group.

J Clin Oncol. 2005 Dec 1;23(34):8717-23. Epub 2005 Oct 31.

PMID:
16260698
11.

[Radiotherapy in stage I testicular seminoma: retrospective study and review of literature].

Bauduceau O, Souleau B, Le-Moulec S, Houlgatte A, Bernard O.

Cancer Radiother. 2003 Dec;7(6):386-94. French.

PMID:
14725912
12.

Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.

Paly JJ, Lin CC, Gray PJ, Hallemeier CL, Beard C, Sineshaw H, Jemal A, Efstathiou JA.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e249-e258. doi: 10.1016/j.prro.2016.05.002. Epub 2016 May 8.

PMID:
27345128
13.

The sword of Damocles and the treatment of stage I seminoma.

Oliver T, Mead G, Mason M, Stenning S, Dieckmann K, Steiner H, De Santis M, Aparicio J, Skoneczna I, Kratzik C.

J Clin Oncol. 2006 Jun 1;24(16):2599-600. No abstract available.

PMID:
16735720
14.

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP; MRC Testicular Tumour Working Party.

Br J Cancer. 2000 Dec;83(12):1623-9.

15.

Adjuvant carboplatin treatment for seminoma clinical stage I.

Dieckmann KP, Krain J, Küster J, Brüggeboes B.

J Cancer Res Clin Oncol. 1996;122(1):63-6.

PMID:
8543595
16.

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Gillessen S.

J Clin Oncol. 2017 Jan 10;35(2):194-200. Epub 2016 Nov 28.

17.

Treatment of stage I seminoma: is it time to change your practice?

Feldman DR, Bosl GJ.

J Hematol Oncol. 2008 Nov 7;1:22. doi: 10.1186/1756-8722-1-22.

18.

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G.

J Clin Oncol. 2011 Feb 20;29(6):719-25. doi: 10.1200/JCO.2010.30.1044. Epub 2011 Jan 4.

PMID:
21205748
19.

Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.

Leung E, Warde P, Jewett M, Panzarella T, O'Malley M, Sweet J, Moore M, Sturgeon J, Gospodarowicz M, Chung P.

BJU Int. 2013 Dec;112(8):1088-95. doi: 10.1111/bju.12330. Epub 2013 Aug 13.

20.

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

Dieckmann KP, Brüggeboes B, Pichlmeier U, Küster J, Müllerleile U, Bartels H.

Urology. 2000 Jan;55(1):102-6.

PMID:
10654903

Supplemental Content

Support Center